InspireMD (NSPR) announced the appointment of Dan Dearen to its Board of Directors. Dearen brings nearly 40 years of leadership experience in the medical device and life sciences sectors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NSPR:
- InspireMD files to sell 16.56M shares of common stock for holders
- InspireMD Inc. Navigates Trade Policy Risks with U.S. Manufacturing Plans
- InspireMD Inc. Reports Q2 2025 Earnings and Regulatory Milestones
- InspireMD’s Earnings Call: FDA Approval and Financial Challenges
- InspireMD Reports Q2 2025 Financial Results and Milestones